138 related articles for article (PubMed ID: 23104454)
1. MELD-sodium score and its prognostic value in malignancy-related ascites of pancreatic and gastric cancer.
Engin H; Bilir C; Ustündağ Y
Support Care Cancer; 2013 Apr; 21(4):1153-6. PubMed ID: 23104454
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Ascites and Serum Sodium in Patients with Low Meld Scores.
Prohic D; Mesihovic R; Vanis N; Puhalovic A
Med Arch; 2016 Feb; 70(1):48-52. PubMed ID: 26980932
[TBL] [Abstract][Full Text] [Related]
3. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
[TBL] [Abstract][Full Text] [Related]
4. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
5. Survival after elective transjugular intrahepatic portosystemic shunt creation: prediction with model for end-stage liver disease score.
Ferral H; Gamboa P; Postoak DW; Albernaz VS; Young CR; Speeg KV; McMahan CA
Radiology; 2004 Apr; 231(1):231-6. PubMed ID: 14990811
[TBL] [Abstract][Full Text] [Related]
6. Applying the original model for end-stage liver disease score rather than the model for end-stage liver disease-Na score for risk stratification prior to transjugular intrahepatic portosystemic shunt procedures.
Lee BT; Yang AH; Urban S; Kim KY; Ter-Oganesyan R; Yuan L; Han HH; Khemichian S; Kahn JA; Kim B
Eur J Gastroenterol Hepatol; 2021 Apr; 33(4):541-546. PubMed ID: 32398491
[TBL] [Abstract][Full Text] [Related]
7. [MELD score in prediction of early mortality in patients suffering refractory ascites treated by TIPS].
Fejfar T; Safka V; Hůlek P; Vanásek T; Krajina A; Jirkovský V
Vnitr Lek; 2006 Sep; 52(9):771-6. PubMed ID: 17091599
[TBL] [Abstract][Full Text] [Related]
8. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
9. Model for End-Stage Liver Disease Sodium as a Predictor of Surgical Risk in Cirrhotic Patients With Ascites.
Maassel NL; Fleming MM; Luo J; Zhang Y; Pei KY
J Surg Res; 2020 Jun; 250():45-52. PubMed ID: 32018142
[TBL] [Abstract][Full Text] [Related]
10. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
11. Model for End-Stage Liver Disease and Sodium Velocity Predicts Overall Survival in Nonmetastatic Hepatocellular Carcinoma Patients.
Tang JY; Ohri N; Kabarriti R; Aparo S; Chuy J; Goel S; Schwartz JM; Kinkhabwala M; Kaubisch A; Guha C
Can J Gastroenterol Hepatol; 2018; 2018():5681979. PubMed ID: 30533403
[TBL] [Abstract][Full Text] [Related]
12. MELD remains the best predictor of mortality in outpatients with cirrhosis and severe ascites.
Jepsen P; Watson H; Macdonald S; Vilstrup H; Jalan R
Aliment Pharmacol Ther; 2020 Aug; 52(3):492-499. PubMed ID: 32573818
[TBL] [Abstract][Full Text] [Related]
13. Child-Pugh, MELD, MELD-Na, and ALBI scores: which liver function models best predicts prognosis for HCC patient with ascites?
Kim KM; Shim SG; Sinn DH; Song JE; Kim BS; Kim HG
Scand J Gastroenterol; 2020 Aug; 55(8):951-957. PubMed ID: 32698637
[TBL] [Abstract][Full Text] [Related]
14. Survival in patients with pancreatic cancer after the diagnosis of malignant ascites or liver metastases by EUS-FNA.
DeWitt J; Yu M; Al-Haddad MA; Sherman S; McHenry L; Leblanc JK
Gastrointest Endosc; 2010 Feb; 71(2):260-5. PubMed ID: 19922924
[TBL] [Abstract][Full Text] [Related]
15. A revised scope in different prognostic models in cirrhotic patients: Current and future perspectives, an Egyptian experience.
Hassan EA; Abd El-Rehim AS
Arab J Gastroenterol; 2013 Dec; 14(4):158-64. PubMed ID: 24433645
[TBL] [Abstract][Full Text] [Related]
16. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma.
Hong YF; Chen ZH; Ma XK; Li X; Wu DH; Chen J; Dong M; Wei L; Wang TT; Ruan DY; Lin ZX; Wen JY; Lin Q; Jia CC; Wu XY
Tumour Biol; 2016 Apr; 37(4):5265-73. PubMed ID: 26561464
[TBL] [Abstract][Full Text] [Related]
17. Abnormal portal venous flow at sonography predicts reduced survival after transjugular intrahepatic portosystemic shunt creation.
Harrod-Kim P; Waldman DL
J Vasc Interv Radiol; 2005 Nov; 16(11):1459-64. PubMed ID: 16319151
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome and predictors of survival after TIPS insertion in patients with liver cirrhosis.
Heinzow HS; Lenz P; Köhler M; Reinecke F; Ullerich H; Domschke W; Domagk D; Meister T
World J Gastroenterol; 2012 Oct; 18(37):5211-8. PubMed ID: 23066315
[TBL] [Abstract][Full Text] [Related]
19. MELD exceptions and new predictive score of death on long waiting lists for liver transplantation.
Iacob S; Gheorghe L; Iacob R; Gheorghe C; Hrehoreţ D; Popescu I
Chirurgia (Bucur); 2009; 104(3):267-73. PubMed ID: 19601457
[TBL] [Abstract][Full Text] [Related]
20. [The predictive value of end-stage liver disease model for spontaneous bacterial peritonitis in cirrhotic patients with ascites].
Wang X; Wang BM; Jiang K; Zhang J; Fang WL; Wang T; Li XY
Zhonghua Nei Ke Za Zhi; 2009 Aug; 48(8):629-32. PubMed ID: 19954052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
